NCT01562314View on ClinicalTrials.gov

A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)

PHASE2CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

May 9, 2012

Primary Completion Date

August 5, 2014

Study Completion Date

August 5, 2014

Conditions

Ulcerative Colitis

Interventions

DRUG

GWP42003

1 to 5 50 mg capsules taken BID

DRUG

Placebo

1 to 5 matching capsules taken BID

Trial Locations (8)

B15 2TH

Birmingham

CV2 2DX

Coventry

L7 8XP

Liverpool

NW1 2PG

London

NW3 2QG

London

SE1 7EH

London

HA1 3UJ

Middlesex

WN1 2NN

Wigan

Sponsors

Lead Sponsor

GW Research Ltd

All Listed Sponsors

lead

GW Research Ltd

INDUSTRY